US 11246950
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
granted A61KA61K2039/505A61K2039/55511
Quick answer
US patent 11246950 (Combination cancer immunotherapy with pentaaza macrocyclic ring complex) held by Galera Labs, LLC expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Galera Labs, LLC
- Grant date
- Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K2039/55511, A61K2039/585, A61K31/555